应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ACRV Acrivon Therapeutics, Inc.
盘前交易 09-18 08:13:15 EDT
7.60
-0.63
-7.65%
最高
8.43
最低
7.53
成交量
21.16万
今开
8.31
昨收
8.23
日振幅
10.94%
总市值
2.35亿
流通市值
8,532万
总股本
3,097万
成交额
167.37万
换手率
1.89%
流通股本
1,123万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Acrivon Therapeutics, Inc.2024财年第二财季实现净利润-18.80百万美元,同比减少35.15%
自选股智能写手 · 08-18
Acrivon Therapeutics, Inc.2024财年第二财季实现净利润-18.80百万美元,同比减少35.15%
Acrivon Therapeutics, Inc.盘中异动 早盘大幅下跌5.44%
自选股智能写手 · 07-12
Acrivon Therapeutics, Inc.盘中异动 早盘大幅下跌5.44%
Acrivon Therapeutics, Inc.盘中异动 股价大涨5.59%
自选股智能写手 · 07-11
Acrivon Therapeutics, Inc.盘中异动 股价大涨5.59%
Acrivon Therapeutics, Inc.盘中异动 下午盘股价大涨5.53%报8.59美元
自选股智能写手 · 05-11
Acrivon Therapeutics, Inc.盘中异动 下午盘股价大涨5.53%报8.59美元
Acrivon Therapeutics, Inc.盘中异动 早盘股价大跌6.05%
自选股智能写手 · 05-06
Acrivon Therapeutics, Inc.盘中异动 早盘股价大跌6.05%
Ladenburg Thalmann:下调Acrivon Therapeutics(ACRV.US)评级,由买入调整至中性评级。
智通财经 · 04-29
Ladenburg Thalmann:下调Acrivon Therapeutics(ACRV.US)评级,由买入调整至中性评级。
Acrivon Therapeutics, Inc.盘中异动 早盘股价大跌5.68%报8.96美元
自选股智能写手 · 04-25
Acrivon Therapeutics, Inc.盘中异动 早盘股价大跌5.68%报8.96美元
Acrivon Therapeutics, Inc.盘中异动 大幅上涨5.91%
自选股智能写手 · 04-15
Acrivon Therapeutics, Inc.盘中异动 大幅上涨5.91%
Acrivon Therapeutics, Inc.盘中异动 早盘大幅下挫5.29%
自选股智能写手 · 04-11
Acrivon Therapeutics, Inc.盘中异动 早盘大幅下挫5.29%
癌症疗法研究公司Acrivon Therapeutics Inc.(ACRV)一度上涨86%,创该公司美国IPO以来最大盘中涨幅,新投资者和现存股东们向该公司投资1.
华尔街见闻 · 04-10
癌症疗法研究公司Acrivon Therapeutics Inc.(ACRV)一度上涨86%,创该公司美国IPO以来最大盘中涨幅,新投资者和现存股东们向该公司投资1.
Acrivon Therapeutics, Inc.盘中异动 下午盘股价大跌7.10%
自选股智能写手 · 04-09
Acrivon Therapeutics, Inc.盘中异动 下午盘股价大跌7.10%
Acrivon Therapeutics, Inc.盘中异动 股价大涨5.92%报6.62美元
自选股智能写手 · 03-26
Acrivon Therapeutics, Inc.盘中异动 股价大涨5.92%报6.62美元
Acrivon Therapeutics, Inc.股价拉升12.61% 市值涨111.49万美元
自选股智能写手 · 03-20
Acrivon Therapeutics, Inc.股价拉升12.61% 市值涨111.49万美元
加载更多
公司概况
公司名称:
Acrivon Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Acrivon Therapeutics, Inc.于2018年3月在特拉华州注册成立。该公司是一家临床阶段生物制药公司,开发精确的肿瘤药物,该公司利用其专有的基于蛋白质组学的患者应答者识别平台,将其与肿瘤预测对每种特定药物敏感的患者相匹配。该公司通过使用其专有的精密药物平台AP3来开发其候选肿瘤药物管道。(该公司的AP3平台能够创建药物专用专有OncoSignature伴随诊断,用于识别最有可能从该公司候选药物中获益的患者,该公司称之为患者应答者)。
发行价格:
--
{"stockData":{"symbol":"ACRV","market":"US","secType":"STK","nameCN":"Acrivon Therapeutics, Inc.","latestPrice":7.6,"timestamp":1726603200000,"preClose":8.23,"halted":0,"volume":211637,"delay":0,"floatShares":11226266,"shares":30972163,"eps":-2.67594,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.63,"latestTime":"09-18 08:13:15 EDT","open":8.31,"high":8.43,"low":7.53,"amount":1673708.0402485002,"amplitude":0.109356,"askPrice":7.83,"askSize":130,"bidPrice":7,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.67594,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726666200000},"adr":0,"listingDate":1668488400000,"adjPreClose":7.6,"postHourTrading":{"tag":"盘后","latestPrice":7.7,"preClose":7.6,"latestTime":"19:56 EDT","volume":2247,"amount":17113.7802,"timestamp":1726617418479},"volumeRatio":1.018399198119698},"requestUrl":"/m/hq/s/ACRV","defaultTab":"news","newsList":[{"id":"2460736031","title":"Acrivon Therapeutics, Inc.2024财年第二财季实现净利润-18.80百万美元,同比减少35.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736031","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736031?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910669,"startTime":"0","endTime":"0","summary":"8月18日,Acrivon Therapeutics, Inc.公布财报,公告显示公司2024财年第二财季净利润为-18.80百万美元,同比减少35.15%;其中营业收入为0.00美元,每股基本收益为-0.52美元。机构评级:截至2024年8月18日,当前有8家机构对Acrivon Therapeutics, Inc.目标价做出预测,其中目标均价为22.00美元,其中最低目标价为17.00美元,最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180007079f3407f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180007079f3407f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","LENZ"],"gpt_icon":0},{"id":"2450537167","title":"Acrivon Therapeutics, Inc.盘中异动 早盘大幅下跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450537167","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450537167?lang=zh_cn&edition=full","pubTime":"2024-07-12 23:23","pubTimestamp":1720797833,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日23时23分,Acrivon Therapeutics, Inc.股票出现波动,股价急速下挫5.44%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.57%。Acrivon Therapeutics, Inc.公司简介:Acrivon Therapeutics Inc是一家临床阶段的生物制药公司,开发肿瘤药物,利用其基于蛋白质组学的患者响应器识别平台,将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712232353aef97dd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712232353aef97dd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2450043361","title":"Acrivon Therapeutics, Inc.盘中异动 股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450043361","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450043361?lang=zh_cn&edition=full","pubTime":"2024-07-11 23:03","pubTimestamp":1720710181,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日23时03分,Acrivon Therapeutics, Inc.股票出现异动,股价大幅拉升5.59%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Acrivon Therapeutics, Inc.公司简介:Acrivon Therapeutics Inc是一家临床阶段的生物制药公司,开发肿瘤药物,利用其基于蛋白质组学的患者响应器识别平台,将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711230302941f6508&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711230302941f6508&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","BK4139","LENZ"],"gpt_icon":0},{"id":"2434201862","title":"Acrivon Therapeutics, Inc.盘中异动 下午盘股价大涨5.53%报8.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434201862","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434201862?lang=zh_cn&edition=full","pubTime":"2024-05-11 01:46","pubTimestamp":1715363169,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日01时46分,Acrivon Therapeutics, Inc.股票出现异动,股价快速拉升5.53%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。Acrivon Therapeutics, Inc.公司简介:Acrivon Therapeutics Inc是一家临床阶段的生物制药公司,开发肿瘤药物,利用其基于蛋白质组学的患者响应器识别平台,将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051101460987e872c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051101460987e872c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2433479785","title":"Acrivon Therapeutics, Inc.盘中异动 早盘股价大跌6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433479785","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433479785?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:44","pubTimestamp":1715003094,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时44分,Acrivon Therapeutics, Inc.股票出现异动,股价急速跳水6.05%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Acrivon Therapeutics, Inc.公司简介:Acrivon Therapeutics Inc是一家临床阶段的生物制药公司,开发肿瘤药物,利用其基于蛋白质组学的患者响应器识别平台,将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621445579260d81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621445579260d81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","BK4139","LENZ"],"gpt_icon":0},{"id":"2431685138","title":"Ladenburg Thalmann:下调Acrivon Therapeutics(ACRV.US)评级,由买入调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431685138","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431685138?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:12","pubTimestamp":1714396351,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ACRV","BK4139","LENZ"],"gpt_icon":0},{"id":"2430285720","title":"Acrivon Therapeutics, Inc.盘中异动 早盘股价大跌5.68%报8.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430285720","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2430285720?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:32","pubTimestamp":1714051943,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时32分,Acrivon Therapeutics, Inc.股票出现异动,股价急速下挫5.68%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.50%。Acrivon Therapeutics, Inc.公司简介:Acrivon Therapeutics Inc是一家临床阶段的生物制药公司,开发肿瘤药物,利用其基于蛋白质组学的患者响应器识别平台,将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213223861e9063&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213223861e9063&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","BK4139","LENZ"],"gpt_icon":0},{"id":"2427005921","title":"Acrivon Therapeutics, Inc.盘中异动 大幅上涨5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427005921","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2427005921?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:31","pubTimestamp":1713187885,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时31分,Acrivon Therapeutics, Inc.股票出现波动,股价快速上涨5.91%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.77%。Acrivon Therapeutics, Inc.公司简介:Acrivon Therapeutics Inc是一家临床阶段的生物制药公司,开发肿瘤药物,利用其基于蛋白质组学的患者响应器识别平台,将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152131258b263f26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152131258b263f26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","BK4139","LENZ"],"gpt_icon":0},{"id":"2426268164","title":"Acrivon Therapeutics, Inc.盘中异动 早盘大幅下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426268164","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426268164?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:42","pubTimestamp":1712842966,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时42分,Acrivon Therapeutics, Inc.股票出现波动,股价快速跳水5.29%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.43%。Acrivon Therapeutics, Inc.公司简介:Acrivon Therapeutics Inc是一家临床阶段的生物制药公司,开发肿瘤药物,利用其基于蛋白质组学的患者响应器识别平台,将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112142467a522cc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112142467a522cc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACRV","LENZ"],"gpt_icon":0},{"id":"2426146830","title":"癌症疗法研究公司Acrivon Therapeutics Inc.(ACRV)一度上涨86%,创该公司美国IPO以来最大盘中涨幅,新投资者和现存股东们向该公司投资1.","url":"https://stock-news.laohu8.com/highlight/detail?id=2426146830","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426146830?lang=zh_cn&edition=full","pubTime":"2024-04-10 01:38","pubTimestamp":1712684306,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2426940375","title":"Acrivon Therapeutics, Inc.盘中异动 下午盘股价大跌7.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426940375","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426940375?lang=zh_cn&edition=full","pubTime":"2024-04-09 02:55","pubTimestamp":1712602510,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日02时55分,Acrivon Therapeutics, Inc.股票出现异动,股价快速下挫7.10%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。Acrivon Therapeutics, Inc.公司简介:Acrivon Therapeutics Inc是一家临床阶段的生物制药公司,开发肿瘤药物,利用其基于蛋白质组学的患者响应器识别平台,将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409025511861e3fae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409025511861e3fae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2422611784","title":"Acrivon Therapeutics, Inc.盘中异动 股价大涨5.92%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422611784","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422611784?lang=zh_cn&edition=full","pubTime":"2024-03-26 22:22","pubTimestamp":1711462957,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日22时22分,Acrivon Therapeutics, Inc.股票出现异动,股价大幅上涨5.92%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Acrivon Therapeutics, Inc.公司简介:Acrivon Therapeutics Inc是一家临床阶段的生物制药公司,开发肿瘤药物,利用其基于蛋白质组学的患者响应器识别平台,将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326222237861e143a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326222237861e143a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2420723652","title":"Acrivon Therapeutics, Inc.股价拉升12.61% 市值涨111.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420723652","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420723652?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:54","pubTimestamp":1710942877,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时54分,Acrivon Therapeutics, Inc.股票出现波动,股价急速上涨12.61%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.02%。Acrivon Therapeutics, Inc.公司简介:Acrivon Therapeutics Inc是一家临床阶段的生物制药公司,开发肿瘤药物,利用其基于蛋白质组学的患者响应器识别平台,将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202154387a4df9f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202154387a4df9f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acrivon.com","stockEarnings":[{"period":"1week","weight":-0.1142},{"period":"1month","weight":0},{"period":"3month","weight":0.1463},{"period":"6month","weight":0.2006},{"period":"1year","weight":-0.2445},{"period":"ytd","weight":0.5447}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acrivon Therapeutics, Inc.于2018年3月在特拉华州注册成立。该公司是一家临床阶段生物制药公司,开发精确的肿瘤药物,该公司利用其专有的基于蛋白质组学的患者应答者识别平台,将其与肿瘤预测对每种特定药物敏感的患者相匹配。该公司通过使用其专有的精密药物平台AP3来开发其候选肿瘤药物管道。(该公司的AP3平台能够创建药物专用专有OncoSignature伴随诊断,用于识别最有可能从该公司候选药物中获益的患者,该公司称之为患者应答者)。","exchange":"NASDAQ","name":"Acrivon Therapeutics, Inc.","nameEN":"Acrivon Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acrivon Therapeutics, Inc.(ACRV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acrivon Therapeutics, Inc.,ACRV,Acrivon Therapeutics, Inc.股票,Acrivon Therapeutics, Inc.股票老虎,Acrivon Therapeutics, Inc.股票老虎国际,Acrivon Therapeutics, Inc.行情,Acrivon Therapeutics, Inc.股票行情,Acrivon Therapeutics, Inc.股价,Acrivon Therapeutics, Inc.股市,Acrivon Therapeutics, Inc.股票价格,Acrivon Therapeutics, Inc.股票交易,Acrivon Therapeutics, Inc.股票购买,Acrivon Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acrivon Therapeutics, Inc.(ACRV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}